HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hughes, G R V Search for Related Content PubMed PubMed Citation Articles by Hughes, G R V Related Collections Other Neurology

Migraine, memory loss, and "multiple sclerosis ". Neurological features of the antiphospholipid (Hughes’) syndrome

Correspondence to:
Correspondence to:
Dr Graham Hughes, Lupus Unit, St Thomas’ Hospital, London SE1 7EH;
graham.hughes{at}kcl.ac.uk

The antiphospholipid syndrome (APS, Hughes’ syndrome), first described in 1983, is a prothrombotic disease in which neurological events feature prominently. Strokes, transient ischaemic attacks, and headaches (including migraine) are important complications. However, it is clear that other neurological symptoms, including diplopia, memory loss, ataxia, and "multiple sclerosis-like" features are common. A notable feature of Hughes’ syndrome is the clinical response to anticoagulants; features such as headache and memory loss often improving dramatically with appropriate warfarin dosage. APS may well become recognised as an important (and potentially treatable) cause of neurological disease.

Keywords: antiphospholipid syndrome; Hughes’ syndrome; migraine; memory loss; "multiple sclerosis"

Abbreviations: APS, antiphospholipid syndrome; INR, international normalised ratio

This article has been cited by other articles:

				A Theodoridou and L Settas Demyelination in rheumatic diseases Postgrad. Med. J., March 1, 2008; 84(989): 127 - 132. [Abstract] [Full Text] [PDF]

				L. ANDREOLI, F. MALACARNE, A. CERIBELLI, I. KUTSCHERA, and A. TINCANI Anti-Cardiolipin and Anti-beta2-Glycoprotein I Antibodies: Performance of New Commercial ELISA Kits Ann. N.Y. Acad. Sci., August 1, 2007; 1109(1): 531 - 537. [Abstract] [Full Text] [PDF]

				A Theodoridou and L Settas Demyelination in rheumatic diseases. J. Neurol. Neurosurg. Psychiatry, March 1, 2006; 77(3): 290 - 295. [Abstract] [Full Text] [PDF]

				M L Bertolaccini and M A Khamashta Laboratory diagnosis and management challenges in the antiphospholipid syndrome Lupus, March 1, 2006; 15(3): 172 - 178. [Abstract] [PDF]

				I Krause, S Lev, A Fraser, M Blank, M Lorber, L Stojanovich, J Rovensky, J Chapman, and Y Shoenfeld Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndrome Ann Rheum Dis, October 1, 2005; 64(10): 1490 - 1493. [Abstract] [Full Text] [PDF]

				G. Ruiz-Irastorza and M. A. Khamashta Stroke and antiphospholipid syndrome: the treatment debate Rheumatology, August 1, 2005; 44(8): 971 - 974. [Abstract] [Full Text] [PDF]

				G. SANNA, M. L. BERTOLACCINI, and G. R. V. HUGHES Hughes Syndrome, the Antiphospholipid Syndrome: A New Chapter in Neurology Ann. N.Y. Acad. Sci., June 1, 2005; 1051(1): 465 - 486. [Abstract] [Full Text] [PDF]

				S. Ferreira, D. P. D'Cruz, and G. R. V. Hughes Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand? Rheumatology, April 1, 2005; 44(4): 434 - 442. [Abstract] [Full Text] [PDF]

				D. D'Cruz and G. R.V. Hughes Lupus and the nervous system Lupus, December 1, 2003; 12(12): 871 - 871. [PDF]

				R Sinharay Sneddon's syndrome: additional neurological feature in antiphospholipid (Hughes') syndrome Postgrad. Med. J., September 1, 2003; 79(935): 550 - 550. [Full Text]